Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy

Archives of Gynecology and Obstetrics

Volumn 285, Issue 5, 2012, Pages 1257-1262

  Rezvan, Neda ^a   Hosseinzadeh Attar, Mohammad Javad ^a   Masoudkabir, Farzad ^a   Moini, Ashraf ^b   Janani, Leila ^a   Mazaherioun, Maryam ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipokines; Gestational diabetes mellitus; Nicotinamide Phosphoribosyltransferase; Visfatin

Indexed keywords

HEMOGLOBIN A1C; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME BLOOD LEVEL; FEMALE; GLYCEMIC CONTROL; HUMAN; MACRONUTRIENT; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY DIABETES MELLITUS; BODY MASS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; NUTRITIONAL ASSESSMENT; ORAL GLUCOSE TOLERANCE TEST; VISFATIN BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; DIET; FEMALE; HUMANS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREGNANCY;

EID: 84862766082     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2156-7     Document Type: Article

References (29)

1. Metzger BE, Coustan DR (1998)Summaryandrecommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161-B167 (Pubitemid 28357050)
2. Dabelea D, Snell-Bergeon JK, Hartsfield CL et al (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579-584 (Pubitemid 40315316)
3. Yudkin JS (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 27(Suppl 3):S25-S28 (Pubitemid 38019184)
4. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919 quiz 920
5. Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
6. Song HK, Lee MH, Kim BK et al (2008)Visfatin:anewplayerin mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 295:F1485-F1494
7. Haider DG, Schaller G, Kapiotis S et al (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909-1914 (Pubitemid 44025046)
8. Revollo JR, Korner A, Mills KF et al (2007) Nampt/PBEF/ Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6:363-375 (Pubitemid 350011996)
9. Filippatos TD, Randeva HS, Derdemezis CS et al (2010)Visfatin/ PBEF and atherosclerosis-related diseases. Curr Vasc Pharmacol 8:12-28
10. Chan TF, Chen YL, Lee CH et al (2006) Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 13:364-367
11. Haider DG, Handisurya A, Storka A et al (2007) Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 30:1889-1891 (Pubitemid 47036375)
12. Lewandowski KC, Stojanovic N, Press M et al (2007) Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 50:1033-1037 (Pubitemid 46559248)
13. Krzyzanowska K, Krugluger W, Mittermayer F et al (2006) Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 110:605-609 (Pubitemid 43736123)
14. Akturk M, Altinova AE, Mert I et al (2008) Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 31:610-613
15. Telejko B, Kuzmicki M, Zonenberg A et al (2009) Visfatin in gestationaldiabetes:serumlevelandm RNAexpressioninfatand placental tissue. Diabetes Res Clin Pract 84:68-75
16. de Luis DA, Aller R, Gonzalez Sagrado M et al (2010) Serum visfatin concentrations are related to dietary intake in obese patients. Ann Nutr Metab 57:265-270
17. ACOG Practice Bulletin (2001) Clinical management guidelines for obstetrician-gynecologists Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 98:525-538
18. Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768-773 (Pubitemid 13196587)
19. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
20. Ma Y, Cheng Y, Wang J et al (2010) The changes of visfatin in serum and its expression in fat and placental tissue in pregnant womenwithgestationaldiabetes.Diabetes Res Clin Pract90:60-65
21. Coskun A, Ozkaya M, Kiran G et al (2010) Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus. J Matern Fetal Neonatal Med 23:1014-1018
22. Morgan SA, Bringolf JB, Seidel ER (2008) Visfatin expression is elevated in normal human pregnancy. Peptides 29:1382-1389
23. Katwa LC, Seidel ER (2009) Visfatin in pregnancy: proposed mechanism of peptide delivery. Amino Acids 37:555-558
24. Berndt J, Kloting N, Kralisch S et al (2005) Plasma visfatin concentrations and fat depot-specific m RNA expression in humans. Diabetes 54:2911-2916 (Pubitemid 41401086)
25. Li L, Yang G, Li Q et al (2006) Changes and relations of circulating visfatin, apelin, andresistin levelsinnormal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 114:544-548 (Pubitemid 46087259)
26. Toruner F, Altinova AE, Bukan N et al (2009) Plasma visfatin concentrations in subjects with type 1 diabetes mellitus. Horm Res 72:33-37
27. Marcinkowska M, Lewandowski KC, Lewinski A et al (2007) Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Endokrynol Pol 58:188-194
28. Lorente-Cebrian S, Bustos M, Marti A et al (2009) Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin Sci (Lond) 117:243-249
29. Wen Y, Wang HW, Wu J et al (2006) Effects of fatty acid regulation on visfatin gene expression in adipocytes. Chin Med J (Engl) 119:1701-1708 (Pubitemid 44697234)